Veradermics (NYSE:MANE) Coverage Initiated by Analysts at Lifesci Capital

Research analysts at Lifesci Capital assumed coverage on shares of Veradermics (NYSE:MANEGet Free Report) in a report issued on Tuesday,Benzinga reports. The firm set an “outperform” rating and a $135.00 price target on the stock. Lifesci Capital’s price target would indicate a potential upside of 43.95% from the company’s current price.

MANE has been the topic of a number of other research reports. Needham & Company LLC initiated coverage on Veradermics in a research report on Tuesday, June 2nd. They issued a “buy” rating and a $136.00 target price on the stock. Wall Street Zen raised Veradermics from a “sell” rating to a “hold” rating in a research report on Sunday. Zacks Research raised Veradermics to a “hold” rating in a research report on Tuesday, March 3rd. Citigroup boosted their target price on Veradermics from $120.00 to $135.00 and gave the company a “buy” rating in a research report on Monday, May 18th. Finally, Weiss Ratings initiated coverage on Veradermics in a research report on Tuesday, May 26th. They issued a “sell (d+)” rating on the stock. Six analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $114.20.

Read Our Latest Analysis on MANE

Veradermics Price Performance

Shares of NYSE MANE traded down $2.49 during midday trading on Tuesday, reaching $93.79. 164,986 shares of the stock were exchanged, compared to its average volume of 492,292. The firm has a 50 day moving average of $90.99. Veradermics has a twelve month low of $32.00 and a twelve month high of $117.71.

Veradermics (NYSE:MANEGet Free Report) last issued its quarterly earnings data on Tuesday, May 12th. The company reported ($1.32) EPS for the quarter, missing the consensus estimate of ($0.56) by ($0.76).

Veradermics Company Profile

(Get Free Report)

MANE is a global manufacturer and supplier of flavors, fragrances and ingredients for the food, beverage, personal care, household and fine fragrance markets. Headquartered in France, the company develops and produces aromatic solutions that are used by consumer goods companies, food processors, perfumers and formulators seeking sensory impact, taste modulation and olfactory character for their products.

The company’s product portfolio includes savory and sweet flavor systems, beverage concentrates, natural extracts, essential oils, fragrance compounds, cosmetic ingredients and specialty functional solutions such as taste enhancers and odor masking agents.

Recommended Stories

Analyst Recommendations for Veradermics (NYSE:MANE)

Receive News & Ratings for Veradermics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradermics and related companies with MarketBeat.com's FREE daily email newsletter.